Lv11
50 积分 2023-11-28 加入
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
3小时前
已完结
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug–Drug Interactions
6天前
已完结
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials
7天前
已完结
Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled Trial
23天前
已完结
Enfortumab Vedotin and Pembrolizumab — A New Perspective on Urothelial Cancer
1个月前
已完结
Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma
2个月前
已完结
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
2个月前
已完结
Risk Factors and Outcomes of Urethral Recurrence Following Radical Cystectomy
5个月前
已完结
A Contemporary Analysis of Urethral Recurrence following Radical Cystectomy
5个月前
已关闭
From Challenges to Solutions: A Review of Fourth-Generation EGFR Tyrosine Kinase Inhibitors to Overcome the C797S Triple Mutation in Non-Small Cell Lung Cancer
5个月前
已完结
皖公网安备34019202002308
